Liver function tests before and after immunosuppressive treatment in the control group
Patient . | ALT (6-53 IU) . | AST (2-60 IU) . | ALP (40-130 IU) . | γGT (10-80 IU) . | ||||
---|---|---|---|---|---|---|---|---|
Before . | After . | Before . | After . | Before . | After . | Before . | After . | |
A | 39 | 25 | 676-150 | 43 | 81 | 89 | 93 | 84 |
B | 11 | 12 | 15 | 19 | 129 | 93 | 27 | 35 |
C | 776-150 | 896-150 | 886-150 | 36 | 82 | 120 | 35 | 1306-150 |
D | 46 | 8046-150 | 656-150 | 8446-150 | 62 | 1486-150 | 26 | 2746-150 |
E | 44 | 11916-150 | 32 | 10486-150 | 93 | 2536-150 | 53 | 1476-150 |
Patient . | ALT (6-53 IU) . | AST (2-60 IU) . | ALP (40-130 IU) . | γGT (10-80 IU) . | ||||
---|---|---|---|---|---|---|---|---|
Before . | After . | Before . | After . | Before . | After . | Before . | After . | |
A | 39 | 25 | 676-150 | 43 | 81 | 89 | 93 | 84 |
B | 11 | 12 | 15 | 19 | 129 | 93 | 27 | 35 |
C | 776-150 | 896-150 | 886-150 | 36 | 82 | 120 | 35 | 1306-150 |
D | 46 | 8046-150 | 656-150 | 8446-150 | 62 | 1486-150 | 26 | 2746-150 |
E | 44 | 11916-150 | 32 | 10486-150 | 93 | 2536-150 | 53 | 1476-150 |
For abbreviations, see Table 5.
Values that were above the normal limits used in our institute.